Search research articles
Contact Us
Filters
Showing results (41-50 of 85) with videos related to
Page
of 9
Sort By:
Molecular Cancer Therapeutics
|
March 5, 2022
Therapeutic Targeting of EZH2 and BET BRD4 in Pediatric Rhabdoid Tumors
Yukitomo Ishi, Yongzhan Zhang, Ali Zhang, et al.
Glia
|
May 7, 2022
A novel mouse model of diffuse midline glioma initiated in neonatal oligodendrocyte progenitor cells highlights cell-of-origin dependent effects of H3K27M
Yusuke Tomita, Yosuke Shimazu, Agila Somasundaram, et al.
Cancer Research
|
November 18, 2015
Targeting a Plk1-Controlled Polarity Checkpoint in Therapy-Resistant Glioblastoma-Propagating Cells
Robin G Lerner, Stefan Grossauer, Banafsheh Kadkhodaei, et al.
Nature Communications
|
March 6, 2019
ACVR1 R206H cooperates with H3.1K27M in promoting diffuse intrinsic pontine glioma pathogenesis
Christine M Hoeman, Francisco J Cordero, Guo Hu, et al.
Nanomedicine (London, England)
|
May 2, 2013
Convection-enhanced delivery of targeted quantum dot-immunoliposome hybrid nanoparticles to intracranial brain tumor models
Kevin C Weng, Rintaro Hashizume, Charles O Noble, et al.
Molecular Cancer Research : MCR
|
March 8, 2019
Potent Antineoplastic Effects of Combined PI3Kα-MNK Inhibition in Medulloblastoma
Frank Eckerdt, Jonathan B Bell, Elspeth M Beauchamp, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 16, 2012
Cooperative interactions of BRAFV600E kinase and CDKN2A locus deficiency in pediatric malignant astrocytoma as a basis for rational therapy
Emmanuelle Huillard, Rintaro Hashizume, Joanna J Phillips, et al.
Cancer Discovery
|
October 28, 2022
Epigenome Programming by H3.3K27M Mutation Creates a Dependence of Pediatric Glioma on SMARCA4
Yan Mo, Shoufu Duan, Xu Zhang, et al.
The Journal of Clinical Investigation
|
May 21, 2024
BET bromodomain inhibition potentiates radiosensitivity in models of H3K27-altered diffuse midline glioma
Jun Watanabe, Matthew R Clutter, Michael J Gullette, et al.
Neuro-Oncology
|
December 6, 2013
Targeting Wee1 for the treatment of pediatric high-grade gliomas
Sabine Mueller, Rintaro Hashizume, Xiaodong Yang, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 85) with videos related to
Sort By:
Page
of 9
Molecular Cancer Therapeutics
|
March 5, 2022
Therapeutic Targeting of EZH2 and BET BRD4 in Pediatric Rhabdoid Tumors
Yukitomo Ishi, Yongzhan Zhang, Ali Zhang, et al.
Glia
|
May 7, 2022
A novel mouse model of diffuse midline glioma initiated in neonatal oligodendrocyte progenitor cells highlights cell-of-origin dependent effects of H3K27M
Yusuke Tomita, Yosuke Shimazu, Agila Somasundaram, et al.
Cancer Research
|
November 18, 2015
Targeting a Plk1-Controlled Polarity Checkpoint in Therapy-Resistant Glioblastoma-Propagating Cells
Robin G Lerner, Stefan Grossauer, Banafsheh Kadkhodaei, et al.
Nature Communications
|
March 6, 2019
ACVR1 R206H cooperates with H3.1K27M in promoting diffuse intrinsic pontine glioma pathogenesis
Christine M Hoeman, Francisco J Cordero, Guo Hu, et al.
Nanomedicine (London, England)
|
May 2, 2013
Convection-enhanced delivery of targeted quantum dot-immunoliposome hybrid nanoparticles to intracranial brain tumor models
Kevin C Weng, Rintaro Hashizume, Charles O Noble, et al.
Molecular Cancer Research : MCR
|
March 8, 2019
Potent Antineoplastic Effects of Combined PI3Kα-MNK Inhibition in Medulloblastoma
Frank Eckerdt, Jonathan B Bell, Elspeth M Beauchamp, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 16, 2012
Cooperative interactions of BRAFV600E kinase and CDKN2A locus deficiency in pediatric malignant astrocytoma as a basis for rational therapy
Emmanuelle Huillard, Rintaro Hashizume, Joanna J Phillips, et al.
Cancer Discovery
|
October 28, 2022
Epigenome Programming by H3.3K27M Mutation Creates a Dependence of Pediatric Glioma on SMARCA4
Yan Mo, Shoufu Duan, Xu Zhang, et al.
The Journal of Clinical Investigation
|
May 21, 2024
BET bromodomain inhibition potentiates radiosensitivity in models of H3K27-altered diffuse midline glioma
Jun Watanabe, Matthew R Clutter, Michael J Gullette, et al.
Neuro-Oncology
|
December 6, 2013
Targeting Wee1 for the treatment of pediatric high-grade gliomas
Sabine Mueller, Rintaro Hashizume, Xiaodong Yang, et al.
Page
of 9